Imax To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Analysts cut targets for CAN, TTAN and BSX, while raising targets for BRZE, VRNS, IMAX, PHVS and CHYM. Ratings largely remained positive.
Keybanc analyst Matthew Gillmor maintains InnovAge Holding (NASDAQ:INNV) with a Overweight and raises the price target from $13 to $14.
Mission Produce rose 5.5% after beating Q3 earnings and sales estimates; several stocks rallied, while ServiceTitan and Evommune fell premarket.